Page 5 - நுண்ணுயிர்க்கொல்லி மருந்துகள் சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நுண்ணுயிர்க்கொல்லி மருந்துகள் சந்தை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நுண்ணுயிர்க்கொல்லி மருந்துகள் சந்தை Today - Breaking & Trending Today

Antibiotics provide no benefit for patients with idiopathic pulmonary fibrosis, study finds


Antibiotics provide no benefit for patients with idiopathic pulmonary fibrosis, study finds
Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a new study has found no benefit for patients with life-threatening idiopathic pulmonary fibrosis in preventing hospitalization or death.
While there were no statistical benefits for patients with the lung-scarring disease, the new research will prevent unnecessary antibiotic use that could contribute to the growing problem of antibiotic resistance. The nationwide clinical trial - believed to be the largest idiopathic pulmonary fibrosis trial ever conducted - also collected biological samples that will advance the understanding and treatment of the mysterious and ultimately fatal illness. ....

United States , Stephenr Wisniewski , Frankc Sciurba , Lauried Snyder , Dong Yun Kim , Hyun Kim , Emily Henderson , Ganesh Raghu , Kevinj Anstrom , Mary Beth Scholand , Anoopm Nambiar , Danielf Dilling , Fernandoj Martinez , Michaelt Durheim , Elizabetha Belloli , Kevinr Flaherty , Eric Yow , Gerardj Criner , Boerhinger Ingelheim , Health Division Of Pulmonary , National Institutes Of Health Heart , Lakes Foundation , Investigators Of The Pulmonary Trials , Journal Of The American Medical Association , Veracyte Inc , Blood Institute ,

Covid patients are more susceptible to secondary infection, says ICMR


Covid patients are more susceptible to secondary infection, says ICMR
May 28, 2021
Study says poor hospital practices, irrational antibiotics usage leading to higher mortality
Poor infection control practices in hospitals and irrational antibiotic prescription practices are triggering secondary infections in Covid-19 patients, leading to a higher mortality, according to a study coordinated by the Indian Council of Medical Research (ICMR).
The study, recently published in the journal
Infection and Drug Resistance, found that out of 17,534 Covid-19 patients admitted in 10 hospitals across the country, 3.6 per cent developed secondary bacterial or fungal infection while in the hospital. The mortality among patients who developed secondary infections was as high as 56.7 per cent compared to an overall mortality of 10.6 per cent among hospitalised Covid 19 patients in general, the study said. ....

Madhya Pradesh , Tamil Nadu , Sonam Vijay , Nitin Bansal , Indian Council Of Medical Research , India Institutes Of Medical Sciences , Indian Council , Medical Research , Drug Resistance , All India Institutes , Medical Sciences , Apollo Hospitals Chennai , Covid 19 , மத்யா பிரதேஷ் , தமிழ் நாடு , நிடின் பன்சால் , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , இந்தியா நிறுவனங்கள் ஆஃப் மருத்துவ அறிவியல் , இந்தியன் சபை , மருத்துவ ஆராய்ச்சி , மருந்து எதிர்ப்பு , அனைத்தும் இந்தியா நிறுவனங்கள் , மருத்துவ அறிவியல் , அப்பல்லோ மருத்துவமனைகள் சென்னை ,